Skip to content

Ardelyx ARDX Operating Cash Flow

Operating Cash Flow at other companies

Amgen logo
AmgenAMGN
$2.19B+57.4%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$230M+9.0%
AbbVie logo
AbbVieABBV
$3.83B+134%
XER
Xeris Biopharma Holdings, Inc.XERS
$9.87M+198%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$145.8M+125%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$32.56M+2,405%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's operating cash flow?
Ardelyx (ARDX) reported operating cash flow of -$32.24M in Q1 2026.
How has Ardelyx's operating cash flow changed year-over-year?
Ardelyx's operating cash flow increased by 16.2% year-over-year, from -$38.46M to -$32.24M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.